Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D (1995) Left atrial size and the risk of stroke and death. The framingham heart study. Circulation 92:835–841. https://doi.org/10.1161/01.cir.92.4.835
Article CAS PubMed Google Scholar
Sanfilippo AJ, Abascal VM, Sheehan M et al (1990) Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 82:792–797. https://doi.org/10.1161/01.cir.82.3.792
Article CAS PubMed Google Scholar
Goldman ME, Pearce LA, Hart RG et al (1999) Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 12:1080–1087. https://doi.org/10.1016/s0894-7317(99)70105-7
Article CAS PubMed Google Scholar
Shively BK, Gelgand EA, Crawford MH (1996) Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke. J Am Coll Cardiol 27:1722–1729. https://doi.org/10.1016/0735-1097(96)00049-6
Article CAS PubMed Google Scholar
Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498. https://doi.org/10.1093/eurheartj/ehaa612
Segal JB, McNamara RL, Miller MR et al (2000) Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 15:56–67. https://doi.org/10.1046/j.1525-1497.2000.04329.x
Article CAS PubMed PubMed Central Google Scholar
Lurie A, Wang J, Hinnegan KJ et al (2021) Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 77:2875–2886. https://doi.org/10.1016/j.jacc.2021.04.036
Frenkel D, D’Amato SA, Al-Kazaz M et al (2016) Prevalence of left atrial thrombus detection by transesophageal echocardiography: A comparison of continuous non-vitamin K antagonist oral anticoagulant versus warfarin therapy in patients undergoing catheter ablation for atrial fibrillation. JACC Clin Electrophysiol 2:295–303. https://doi.org/10.1016/j.jacep.2016.01.004
Durmaz E, Karpuz MH, Bilgehan K et al (2020) Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study. Int J Cardiovasc Imaging 36:1097–1103. https://doi.org/10.1007/s10554-020-01811-x
Alqarawi W, Birnie DH, Spence S et al (2019) Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants. Europace 21:48–53. https://doi.org/10.1093/europace/euy129
Côté G, Denault A (2008) Transesophageal echocardiography-related complications. Can J Anaesth 55:622–647. https://doi.org/10.1007/bf03021437
Cho MS, Yun JE, Park JJ et al (2020) Pattern and impact of off-label underdosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation who are indicated for standard dosing. Am J Cardiol 125:1332–1338. https://doi.org/10.1016/j.amjcard.2020.01.044
Article CAS PubMed Google Scholar
Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962. https://doi.org/10.1093/eurheartj/ehw210
January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:2071–2104. https://doi.org/10.1161/cir.0000000000000040
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272. https://doi.org/10.1378/chest.09-1584
Hahn RT, Abraham T, Adams MS et al (2013) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 26:921–964. https://doi.org/10.1016/j.echo.2013.07.009
Saric M, Armour AC, Arnaout MS et al (2016) Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism. J Am Soc Echocardiogr 29:1–42. https://doi.org/10.1016/j.echo.2015.09.011
Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791. https://doi.org/10.1093/eurheartj/ehx391
Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 143:e72–e227. https://doi.org/10.1161/cir.0000000000000923
Vahanian A, Beyersdorf F, Praz F et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 75:524. https://doi.org/10.1016/j.rec.2022.05.006
Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463. https://doi.org/10.1016/j.echo.2005.10.005
Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003
Sullivan LM, Massaro JM, D’Agostino RB Sr (2004) Presentation of multivariate data for clinical use: The framingham study risk score functions. Stat Med 23:1631–1660. https://doi.org/10.1002/sim.1742
Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781. https://doi.org/10.1016/s0895-4356(01)00341-9
Article CAS PubMed Google Scholar
Wegner FK, Radke R, Ellermann C et al (2022) Incidence and predictors of left atrial appendage thrombus on transesophageal echocardiography before elective cardioversion. Sci Rep 12:3671. https://doi.org/10.1038/s41598-022-07428-5
Article CAS PubMed PubMed Central Google Scholar
Yang S, Zhang Y, Chen N et al (2023) Characteristics, thrombus resolution, and long-term outcomes in patients with nonvalvular atrial fibrillation and atrial thrombus. Clin Appl Thromb Hemost 29:10760296231168097. https://doi.org/10.1177/10760296231168097
Article CAS PubMed PubMed Central Google Scholar
Lee WC, Fang CY, Chen YL et al (2019) Left atrial or left atrial appendage thrombus resolution after adjustment of oral anticoagulant treatment. J Stroke Cerebrovasc Dis 28:90–96. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.015
McCready JW, Nunn L, Lambiase PD et al (2010) Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? Europace 12:927–932. https://doi.org/10.1093/europace/euq074
Comments (0)